[AlaskaAngel]

As a National Cancer Institute site, Fred Hutch is among the most reputable.

Even though there are patients who feel they have given full consideration to the information commonly made available to patients at time of diagnosis and decision-making, discussion in materials provided implies only that those who have a return of breast cancer are just experiencing the "failure" of their chosen chemotherapy.

In the statistical presentations of such analyses as lifemath or Adjuvant Online! that often are used at time of diagnosis for help in understanding one's risks and benefits, I didn't see any consideration specifically stated to be provided for the possibility that in some instances the chosen chemo might actually be encouraging the growth of breast cancer, but maybe someone else has seen something in those sources that I have not seen?

If none of the statisticians gave clear consideration and allocation for that possibility, how useful would those decision tools be, and what else might be missing from them?

A.A.